Navigation Links
Telik Announces Presentation at ASCO Annual Meeting
Date:5/21/2009

PALO ALTO, Calif., May 21 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced today that the results from the randomized clinical study of canfosfamide (TELCYTA(R), TLK286) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD will be presented at the 45th annual meeting of the American Society of Clinical Oncology (ASCO) which will be held from May 29 to June 2 in Orlando, FL.

Details of the presentation are as follows:

           -- Abstract #5552 - General Poster Session, Gynecologic Cancer;
              Sunday, May 31, 2009, 2:00-6:00pm EDT; Level 2, West Hall C

              Title:  "Randomized phase III study of canfosfamide (C, TLK286)
              plus pegylated liposomal doxorubicin (PLD) versus PLD as
              second-line therapy in platinum (P) refractory or resistant
              ovarian cancer (OC)."

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
2. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
5. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
6. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
7. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
8. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
9. Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
10. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
11. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 Unchained Labs, ... out to this year,s PEGS conference and launches the ... system for biologics. PEGS: The Essential Protein Engineering Summit ... 4-8, 2015. The UNit lets drug discovery ... other tool out there. Its 7 applications, 144 sample ...
(Date:5/4/2015)... , May 4, 2015 ... of Michael Williams into the newly ... Williams is a senior pharmaceutical executive with world-class ... also long and distinguished service at industry leaders ... expertise spans a broad range of therapeutic areas, ...
(Date:5/4/2015)... 4, 2015 CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to treat critically-ill and ... report Q1 2015 financial results after the market ... CytoSorbents, management will host a live conference ... operational and financial progress during Q1 2015 followed ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... Inc. (OTCPK: ILNS) announces that Dr. Daniel G. ... the 10TH Annual BIO Investor Forum.  Hosted by ... seeking capital, distribution, and visibility with investors and ... healthcare companies. The meeting will take place January ...
... Calif., Dec. 14, 2011  AtheroNova Inc. (OTCBB: AHRO) ... and development of compounds to regress atherosclerotic plaque ... I and Phase II protocol outlines, based on ... New Drug) meeting with the U.S. Food and ...
Cached Medicine Technology:Intellect Neurosciences, Inc. to Present at OneMedForum 2Intellect Neurosciences, Inc. to Present at OneMedForum 3FDA Agrees With AtheroNova's Clinical Development Plan as Proposed 2FDA Agrees With AtheroNova's Clinical Development Plan as Proposed 3
(Date:5/4/2015)... (PRWEB) May 04, 2015 The Lymphoma ... devoted exclusively to funding innovative lymphoma research and serving ... programs, outreach initiatives and patient services – is set ... historic Mayfair Farms in West Orange, NJ on June ... $500,000 for innovative research programs through LRF. , This ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 In May of ... took his own life. In the wake of this tragedy, ... Silent, an organization that exposes the grim reality of bullying ... a platform for Kirk and Laura to share their story ... tragedy from happening to another family — a mission that ...
(Date:5/4/2015)... York, NY (PRWEB) May 04, 2015 Ticket ... 2015 International Champions Cup (ICC) . While the ... world and is held every four years, the International Champions ... year, the tournament saw the all-time attendance record for soccer ... Madrid from the Big House at the University of Michigan. ...
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... of atorvastatin, a type of cholesterol-lowering drug, found that ... levels, it did inhibit expression of cellular markers of ... Since immune activation and inflammation are associated with progression ... may inhibit disease progression and help in the infection,s ...
... 16 (HealthDay News) -- The way women draw themselves ... researchers suggest. They found that women with anorexia ... without eating disorders. The study, by Israeli researchers, ... women with no eating disorder, half of them overweight ...
... 16 (HealthDay News) -- Americans living in parts of ... physically active in their free time, according to federal ... the least likely to be physically active during leisure ... Physical inactivity rates are 29.2 percent or greater for ...
... A University of Minnesota research team was recently ... from the National Science Foundation,s Cyber-Enabled Discovery and ... vision algorithms that will assist with the early ... such as autism, attention deficit disorder (ADD) and ...
... dropping out are particularly sensitive to a handful of critical ... a study led by Michigan State University scholars. Surprisingly, ... and students, failure to get their intended major did not ... said Tim Pleskac, MSU assistant professor of psychology and lead ...
... of children developmental disabilities such as Down syndrome and ... lower school performance, according to a new study led ... "When a child has a disability, all ... lead author Debra Lobato, Ph.D., of the Bradley Hasbro ...
Cached Medicine News:Health News:Trial suggests statin may affect markers associated with progression of HIV 2Health News:Self-Drawings May Reveal Hidden Eating Disorders 2Health News:Appalachia, the South Home to Least-Active Americans: CDC 2Health News:University of Minnesota researchers study the use of computer vision to diagnose mental disorders 2Health News:MSU-led study identifies risks for quitting college 2Health News:Latino siblings of children with developmental disabilities at risk 2Health News:Latino siblings of children with developmental disabilities at risk 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: